CaÑeda, Rhyle M.
HRN: 25-67-39 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2025
AMPICILLIN 1GM (VIAL)
11/27/2025
12/04/2025
IV
390MG
Q6H
PCAPC
Checking Final Appropriateness
11/30/2025
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
11/30/2025
12/04/2025
PO
3ml
Q 12
PCAP-C
Checking Initial Appropriateness